Inovio Pharmaceuticals Inc (INO) — Strategic Asset Allocation Index
Inovio Pharmaceuticals Inc (INO) has a Strategic Asset Allocation Index of 10.8% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $3.09 Million) total $3.09 Million, measured against net assets of $28.53 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Inovio Pharmaceuticals Inc Strategic Asset Allocation Index (1999–2024)
This chart shows how Inovio Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 26 annual periods from 1999 to 2024. As of June 2025, the index stands at 10.8%, representing strategic assets of $3.09 Million against net assets of $28.53 Million USD. Explore INO cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Inovio Pharmaceuticals Inc (1999–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Inovio Pharmaceuticals Inc from 1999 to 2024, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Inovio Pharmaceuticals Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 2.4% | $1.61 Million | $- | $1.61 Million | $68.50 Million | ▼ 0.0 pp |
| 2023 | 2.4% | $2.78 Million | $- | $2.78 Million | $117.35 Million | ▼ -2.0 pp |
| 2022 | 4.4% | $9.74 Million | $7.73 Million | $2.01 Million | $222.36 Million | ▼ -1.0 pp |
| 2021 | 5.3% | $21.36 Million | $17.45 Million | $3.91 Million | $399.67 Million | ▲ +2.8 pp |
| 2020 | 2.6% | $11.78 Million | $11.35 Million | $434.39K | $461.14 Million | ▼ -350.6 pp |
| 2019 | 353.2% | $19.09 Million | $12.77 Million | $6.32 Million | $5.40 Million | ▲ +327.5 pp |
| 2018 | 25.7% | $22.33 Million | $15.95 Million | $6.38 Million | $87.03 Million | ▲ +6.4 pp |
| 2017 | 19.2% | $27.39 Million | $18.32 Million | $9.07 Million | $142.49 Million | ▼ -4.2 pp |
| 2016 | 23.4% | $28.86 Million | $9.03 Million | $19.83 Million | $123.38 Million | ▲ +7.9 pp |
| 2015 | 15.5% | $27.30 Million | $7.31 Million | $19.99 Million | $175.93 Million | ▼ -0.1 pp |
| 2014 | 15.7% | $17.47 Million | $4.58 Million | $12.89 Million | $111.54 Million | ▲ +10.2 pp |
| 2013 | 5.5% | $2.89 Million | $2.89 Million | $- | $52.90 Million | ▲ +4.4 pp |
| 2012 | 1.0% | $363.02K | $363.02K | $- | $34.86 Million | ▼ -18.7 pp |
| 2011 | 19.8% | $9.47 Million | $295.79K | $9.17 Million | $47.86 Million | ▲ +19.2 pp |
| 2010 | 0.6% | $277.00K | $277.00K | $- | $47.10 Million | ▲ +0.0 pp |
| 2009 | 0.6% | $343.00K | $343.00K | $- | $61.18 Million | ▼ -1.3 pp |
| 2008 | 1.9% | $354.00K | $354.00K | $- | $19.11 Million | ▲ +0.6 pp |
| 2007 | 1.3% | $402.00K | $402.00K | $- | $31.03 Million | ▼ -0.4 pp |
| 2006 | 1.7% | $391.00K | $391.00K | $- | $23.50 Million | ▲ +0.1 pp |
| 2005 | 1.6% | $376.00K | $376.00K | $- | $23.47 Million | ▲ +0.6 pp |
| 2004 | 1.0% | $155.00K | $155.00K | $- | $15.55 Million | ▼ -0.2 pp |
| 2003 | 1.2% | $176.00K | $176.00K | $- | $15.05 Million | ▼ -6.7 pp |
| 2002 | 7.9% | $295.00K | $295.00K | $- | $3.73 Million | ▼ -5.1 pp |
| 2001 | 13.1% | $648.00K | $648.00K | $- | $4.96 Million | ▲ +3.9 pp |
| 2000 | 9.1% | $904.00K | $904.00K | $- | $9.89 Million | ▲ +0.6 pp |
| 1999 | 8.6% | $1.01 Million | $1.01 Million | $- | $11.83 Million | — |